Sightfresh for Dry Eyes: Can It Actually Help? A Dietitian’s Honest Take
Sightfresh contains several anti-inflammatory and antioxidant ingredients — including Quercetin, Bilberry Extract, and Eyebright — that may provide meaningful complementary support for dry eye syndrome. That said, Sightfresh was designed primarily to support macular health, and it lacks Omega-3 fatty acids (DHA and EPA), which carry the strongest clinical evidence for dry eye relief. My honest bottom line: Sightfresh can be a reasonable addition for people managing both macular concerns and dry eye, but it should not be your first or only choice if dry eye is your primary complaint.
TL;DR — Sightfresh for Dry Eyes
- Sightfresh’s anti-inflammatory ingredients (Quercetin 500 mg, Bilberry 160 mg, Eyebright 400 mg) may reduce ocular surface inflammation, a key driver of dry eye symptoms
- The formula provides solid macular antioxidant support via Lutein and Zeaxanthin, which also protect the ocular surface from oxidative stress
- Sightfresh is not a dedicated dry eye supplement — it lacks Omega-3 fatty acids, which are the most clinically supported nutritional intervention for dry eye
- Best candidate: adults managing both macular health concerns and dry eye who want one multi-purpose formula, especially if they already supplement with Omega-3s separately
- Backed by a 60-day money-back guarantee, making it low-risk to assess your own response over 60–90 days
Check Current Pricing on the Official Website{rel=“nofollow sponsored”}
What Causes Dry Eye Syndrome?
Dry eye syndrome is one of the most prevalent ocular conditions in the United States, affecting an estimated 16 million adults — and that figure almost certainly undercounts the millions more who experience occasional symptoms but haven’t received a formal diagnosis. If you’ve noticed that persistent gritty sensation, unexplained light sensitivity, or the paradox of watery eyes that still feel dry, you are in well-documented company.
Understanding what actually causes dry eye matters because it determines which interventions — drops, supplements, lifestyle changes — are targeting the right mechanism for your specific situation.
The three-part problem: tear film instability
The tear film that coats your eye’s surface isn’t simply water. It’s a carefully layered structure: a mucin layer anchored to the ocular surface, an aqueous (watery) middle layer produced by the lacrimal glands, and an outer lipid layer secreted by the meibomian glands along the eyelid margins. This lipid layer is the lid that prevents rapid evaporation. When any layer is compromised, the tear film destabilizes, the corneal surface dries out between blinks, and the characteristic burning-gritty-foreign-body sensation follows.
The inflammation loop
Here is what makes dry eye so persistent and why nutritional interventions have attracted serious research interest: ocular surface dryness triggers an inflammatory cascade. Stressed corneal epithelial cells release pro-inflammatory cytokines, which recruit immune cells to the ocular surface, which produce more inflammation, which further disrupts the tear film. It is a self-reinforcing cycle. Breaking that cycle — not just lubricating over it — is the principle underlying nutritional approaches to dry eye management.
Evaporative vs. aqueous-deficient dry eye
Clinically, most dry eye falls into one of two broad categories. Aqueous-deficient dry eye occurs when the lacrimal glands simply don’t produce enough tear volume. Evaporative dry eye — by far the more common form, accounting for roughly 85% of cases — occurs when meibomian gland dysfunction compromises the lipid layer and tears evaporate faster than the lacrimal glands can replace them. Omega-3 fatty acids are thought to work partly by supporting meibomian gland secretion quality, which is why they are the most clinically studied nutritional intervention for evaporative dry eye specifically.
This context matters for evaluating Sightfresh’s relevance: the formula’s ingredients are primarily oriented toward reducing inflammation and oxidative stress, which addresses one part of the dry eye equation — but not the evaporative component as directly as Omega-3s would.
Sightfresh’s Ingredients Relevant to Dry Eye
Sightfresh was formulated around an AREDS2-inspired core — protecting macular pigment density and retinal health — but several of its ingredients have documented anti-inflammatory and antioxidant mechanisms that are directly relevant to the dry eye disease process. Here is a full breakdown of how each relevant ingredient maps onto the dry eye literature. For complete formula analysis, see our Sightfresh Ingredients deep-dive.
Bilberry Extract — 160 mg
Bilberry (Vaccinium myrtillus) is rich in anthocyanins — a class of flavonoid pigments with well-documented antioxidant and capillary-stabilizing properties. In the context of the eye, bilberry’s most studied mechanism is retinal capillary support: anthocyanins appear to strengthen capillary walls and improve microcirculation in the retinal and choroidal vasculature.
For dry eye specifically, the relevant mechanism is indirect but biologically plausible. The lacrimal gland and the meibomian glands are both highly vascularized structures. Improved microvascular circulation — ensuring these glands receive adequate nutrient and oxygen supply — supports their secretory function. A 2014 study published in Nutrients examining flavonoid-rich bilberry extract found measurable improvements in visual acuity and subjective visual fatigue in participants who spent extended time on digital screens, a condition strongly associated with reduced blink rate and increased tear film evaporation. The 160 mg dose in Sightfresh is within the range used in published studies (typically 120–160 mg standardized to 25% anthocyanins).
For a broader look at the evidence on this ingredient, see our Bilberry for Eye Health analysis.
Quercetin — 500 mg
Quercetin is arguably the most directly relevant ingredient in Sightfresh’s formula for dry eye, and at 500 mg it is dosed meaningfully. Quercetin is a flavonoid with potent anti-inflammatory properties, documented across multiple mechanisms: it inhibits release of histamine from mast cells, downregulates NF-kB signaling (a master regulator of inflammatory gene expression), and suppresses production of pro-inflammatory prostaglandins.
Why does this matter for dry eye? Ocular surface inflammation — the self-reinforcing cytokine cascade described above — is precisely the mechanism Quercetin’s anti-inflammatory action targets. A 2021 review in Frontiers in Pharmacology documented Quercetin’s ability to inhibit key inflammatory mediators including IL-1β, TNF-α, and IL-6, all of which are elevated in the tear fluid of dry eye patients compared to healthy controls.
It’s worth being clear: there are no large randomized controlled trials specifically testing Quercetin supplementation for dry eye disease endpoints like TBUT (tear break-up time) or Schirmer scores. The mechanistic evidence is robust, but direct clinical trial confirmation in dry eye populations is limited. That is a fair caveat — Quercetin’s promise for dry eye is grounded in mechanism, not yet in the kind of condition-specific RCT evidence we have for Omega-3s.
Eyebright — 400 mg
Eyebright (Euphrasia officinalis) has been used in European traditional medicine for ocular irritation and inflammation for centuries — its very name reflects this history. Modern phytochemical analysis has identified iridoid glycosides, flavonoids, and tannins as its primary active compounds, with documented astringent and anti-inflammatory properties.
Eyebright is most frequently studied as a topical preparation — eye drops containing Euphrasia extracts have shown modest evidence for reducing inflammatory symptoms in conjunctivitis. The evidence base for oral Eyebright supplementation specifically for dry eye is thinner than for Quercetin or Bilberry. However, its anti-inflammatory flavonoid content suggests mechanistic relevance, and at 400 mg it is present at a meaningful dose rather than a token amount.
I view Eyebright as a supportive ingredient in the context of dry eye — unlikely to be the primary driver of any benefit, but contributing to the overall anti-inflammatory profile of the formula.
Lutein and Zeaxanthin
Lutein and Zeaxanthin are the carotenoids that concentrate in the macula (as macular pigment) and are the foundation of Sightfresh’s AREDS2-aligned core. Their dry eye relevance is primarily through antioxidant protection of the ocular surface.
The corneal epithelium and conjunctival tissues are exposed to ultraviolet radiation and environmental oxidative stressors continuously. Lutein and Zeaxanthin accumulate not only in the retina but in the lens and corneal tissues, where they quench reactive oxygen species before oxidative damage can trigger or amplify inflammatory signaling. A 2017 study in Nutrients found that dietary Lutein supplementation was associated with improved antioxidant defense in the ocular surface tissues of participants with mild dry eye.
This is a protective mechanism rather than a direct tear film production mechanism — Lutein and Zeaxanthin help maintain ocular surface integrity, which reduces the threshold at which environmental stressors trigger inflammation.
For the broader evidence on these carotenoids, see our Lutein and Zeaxanthin for Vision guide.
Summary table: Sightfresh ingredients and dry eye relevance
| Ingredient | Dose | Dry Eye Mechanism | Evidence Grade |
|---|---|---|---|
| Quercetin | 500 mg | Anti-inflammatory; inhibits cytokine cascade on ocular surface | Mechanistic (strong); clinical RCT (limited) |
| Bilberry Extract | 160 mg | Capillary support for lacrimal/meibomian gland perfusion; antioxidant | Mechanistic + some clinical data |
| Eyebright | 400 mg | Anti-inflammatory; traditional ocular surface support | Traditional + limited modern clinical |
| Lutein | Formula dose | Antioxidant protection of cornea and conjunctiva | Mechanistic + observational |
| Zeaxanthin | Formula dose | Antioxidant protection of ocular surface | Mechanistic + observational |
What Sightfresh Is Missing for Dry Eye
Being honest about what a supplement lacks is just as important as crediting what it contains. Sightfresh has a meaningful anti-inflammatory and antioxidant profile, but it has one significant gap for dry eye — and it is the single most important ingredient category in the dry eye supplement literature.
Omega-3 fatty acids (DHA and EPA): the strongest evidence for dry eye
Multiple systematic reviews and large randomized controlled trials have established Omega-3 fatty acids — specifically the long-chain marine forms, DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) — as the most clinically supported nutritional intervention for dry eye syndrome.
The mechanisms are multifactorial:
-
Meibomian gland function. Omega-3s are incorporated into the phospholipid membranes of meibomian gland secretory cells and influence the melting-point and flow characteristics of the meibum (the lipid that forms the outer tear film layer). More fluid meibum spreads more evenly across the tear film, reducing evaporation.
-
Anti-inflammatory effects. EPA is a precursor to anti-inflammatory eicosanoids (resolvins, protectins) that directly reduce ocular surface inflammatory signaling — complementary to but distinct from Quercetin’s flavonoid-mediated anti-inflammatory action.
-
Lacrimal gland support. Omega-3 deficiency is associated with reduced lacrimal gland secretory capacity, and supplementation has shown improvements in aqueous tear production in deficient populations.
The 2018 Dry Eye Assessment and Management (DREAM) study — a 3,000-participant NIH-funded RCT — tested high-dose Omega-3 supplementation (EPA 3,000 mg + DHA 1,500 mg daily) versus olive oil placebo for 12 months in people with moderate-to-severe dry eye. Results were mixed at that high dose, but the broader meta-analytic literature (including a 2019 Cochrane-adjacent review spanning 34 trials) consistently shows benefit for lower-grade dry eye at doses of 1,000–2,000 mg EPA+DHA combined.
Sightfresh contains zero Omega-3 fatty acids. Its formula is built around fat-soluble carotenoids and water-soluble flavonoids — not the long-chain fatty acids that most directly address tear film lipid layer quality. For a supplement designed primarily around macular protection, this makes complete sense. But it is a meaningful gap for anyone evaluating Sightfresh as a dry eye solution.
For our full review of the Dry Eye Supplements Evidence, including a comparison of Omega-3 formulations, see that dedicated guide.
Who Should Consider Sightfresh for Dry Eye Support?
Given an honest assessment of both the relevant ingredients and the Omega-3 gap, Sightfresh occupies a specific and reasonable niche for dry eye — not as a standalone dry eye treatment, but as a complementary formula in specific circumstances. Here is how to think about whether you are a good candidate.
Adults Managing Both Macular Health and Dry Eye
This is the clearest use case for Sightfresh as a dry eye-relevant supplement. If you have been told you have early macular changes, a family history of AMD, or are in an age group (50+) where macular protection becomes a clinical priority — and you also experience mild to moderate dry eye symptoms — Sightfresh’s dual anti-inflammatory and macular-antioxidant profile makes it a genuinely efficient choice.
Rather than taking a dedicated macular formula (Lutein/Zeaxanthin/Zinc) plus a separate anti-inflammatory botanical blend, Sightfresh consolidates multiple mechanisms into a single formula. The Quercetin and Bilberry contribute meaningful anti-inflammatory action that may reduce the ocular surface inflammation component of your dry eye, while the carotenoid core addresses the retinal photoreceptor protection you also need.
Those Who Already Take Omega-3s Separately
If you are already taking a quality fish oil or algae-based Omega-3 supplement (targeting 1,000–2,000 mg EPA+DHA per day), adding Sightfresh provides complementary anti-inflammatory and antioxidant coverage that doesn’t duplicate what you’re already doing. The two formulas address dry eye through different — and additive — mechanisms: Omega-3s primarily support meibomian gland function and lipid layer quality; Sightfresh’s anti-inflammatory botanicals target the inflammatory cytokine cascade on the ocular surface.
This combination represents a more comprehensive nutritional approach to dry eye management than either category alone.
People With Screen-Fatigue-Related Dry Eye
Extended screen time reduces blink rate significantly — from a normal rate of roughly 15–20 blinks per minute to as few as 5–7 blinks per minute during focused screen use. This reduced blink rate accelerates tear film evaporation, and digital eye strain with associated dry eye symptoms is one of the fastest-growing presentations in ophthalmology clinics. Bilberry Extract at 160 mg has shown the most direct evidence for reducing visual fatigue and improving comfort in screen-heavy populations — a specific mechanism that is particularly relevant to this increasingly common dry eye subtype.
Who Should Probably Look Elsewhere
If dry eye syndrome is your primary and sole complaint — if you have no macular concerns, are under 45, and are specifically seeking the most targeted nutritional support for tear film and ocular surface health — dedicated Omega-3 supplementation is a better-evidenced first step than Sightfresh. A quality fish oil delivering 1,000–2,000 mg EPA+DHA per day is both more directly relevant to the condition and typically lower in cost.
You can always add Sightfresh for complementary anti-inflammatory and antioxidant coverage once your Omega-3 baseline is established — but if you can only invest in one supplement for dry eye, make it Omega-3s. See our full Sightfresh Review for more on the formula’s overall design intent.
Eye Drops vs Eye Supplements — Which Works Better for Dry Eye?
This is one of the most common questions I hear from patients navigating dry eye management, and the honest answer is that it’s the wrong question — because eye drops and oral supplements address fundamentally different parts of the problem. They are complements, not competitors.
What Eye Drops Do (and Don’t Do)
Over-the-counter artificial tears and lubricating eye drops work by temporarily replacing or supplementing the aqueous layer of the tear film. They provide immediate relief — within seconds to minutes — from the surface irritation, grittiness, and discomfort that comes from an unstable, insufficient tear film. For acute symptom management, they are indispensable.
What they don’t do is address the underlying causes of tear film instability. Artificial tears don’t reduce the inflammatory cytokine signaling on the ocular surface. They don’t improve meibomian gland function or the lipid layer quality that prevents rapid tear evaporation. They don’t provide the nutritional substrates that lacrimal gland secretory cells need to produce adequate tear volume. You need to re-apply them repeatedly because they’re managing symptoms, not modifying the biological processes driving those symptoms.
Prescription eye drops are more disease-modifying: cyclosporine A (Restasis) and lifitegrast (Xiidra) are FDA-approved treatments that work by suppressing the T-cell-mediated inflammatory response on the ocular surface. These are meaningful interventions for moderate-to-severe dry eye disease — and they represent the pharmacological parallel to the anti-inflammatory nutritional approach. The mechanisms are different (immunosuppressant drugs vs. anti-inflammatory nutrients), but they target the same inflammation loop.
What Oral Supplements Do
Oral supplements for dry eye — Omega-3s most prominently, with anti-inflammatory botanicals as complementary support — work through systemic mechanisms that manifest at the ocular surface over weeks to months, not hours. They are slow, foundational, and root-cause oriented rather than symptom-oriented.
Omega-3s circulate to the meibomian glands and influence their secretory output. Anti-inflammatory flavonoids like Quercetin reduce systemic and local inflammatory tone. Antioxidants like Lutein protect corneal and conjunctival tissue integrity. None of these happen fast enough to give you relief during a bad dry eye afternoon — but they can shift the baseline over 60–90 days in ways that OTC artificial tears alone cannot.
For a detailed overview of the evidence on which nutritional interventions are most supported, our Evidence on Eye Vitamins guide covers the literature systematically.
The Practical Recommendation: Use Both, for Different Jobs
For most people managing mild-to-moderate dry eye:
- Eye drops: use for acute symptom relief, particularly in high-evaporation environments (air-conditioned offices, airplane cabins, long screen sessions). Preservative-free formulations are preferred for frequent users.
- Omega-3 supplementation: 1,000–2,000 mg EPA+DHA daily as the primary nutritional foundation for meibomian gland support and anti-inflammatory benefit.
- Broad antioxidant/anti-inflammatory formula (like Sightfresh): appropriate complementary addition, particularly if you have concurrent macular health concerns or are looking for multi-mechanism botanical anti-inflammatory support.
This layered approach — acute symptomatic relief + foundational nutritional support + targeted antioxidant coverage — reflects how dry eye is increasingly managed in integrative ophthalmology practice.
Try Sightfresh Risk-Free — 60-Day Money-Back Guarantee
Sightfresh’s anti-inflammatory ingredients may provide complementary support for dry eye alongside its core macular formula. The 60-day money-back guarantee gives you a full two months to assess your personal response.
Visit the Official Sightfresh Website{rel=“nofollow sponsored”}
What Results Can You Expect? Realistic Timelines for Dry Eye Support
Setting accurate expectations for nutritional supplement timelines is, in my view, one of the most important parts of evaluating whether a product is working for you — because the most common reason people abandon supplements that might have helped them is simply running out of patience before the compounds have had time to accumulate and act.
Weeks 1–4: Unlikely to notice changes in dry eye
The first four weeks of any nutritional supplement intervention are primarily pharmacokinetic — the active compounds are being absorbed, distributed, and reaching steady-state concentrations in relevant tissues. Quercetin, for instance, needs time to establish consistent plasma levels. Lutein and Zeaxanthin accumulate in ocular tissues over months, not weeks. During this phase, your eye drops remain your primary symptom management tool, and that’s appropriate.
Some users report reduced eye fatigue or improved comfort during extended screen sessions within the first three to four weeks, which may reflect Bilberry’s relatively faster-acting effects on microcirculation and visual fatigue. This tends to be the first signal, when it appears.
Weeks 4–8: Potential early anti-inflammatory shifts
The anti-inflammatory mechanisms — particularly Quercetin’s inhibition of inflammatory signaling cascades — may begin to produce measurable effects on ocular surface inflammation during this window. In practice, this might register as slightly less morning dryness, improved comfort in low-humidity environments, or reduced reliance on eye drops on better days. These are subtle shifts, not dramatic transformations.
Weeks 8–12: Meaningful assessment window
The 60–90 day window is the appropriate point for a genuine assessment of whether Sightfresh is contributing meaningfully to your dry eye comfort. At this point, antioxidant coverage of the ocular surface tissues is established, any anti-inflammatory effects are at or near steady state, and you have enough experience with the formula to identify a real pattern versus day-to-day variability.
If you are combining Sightfresh with an Omega-3 supplement, the Omega-3 effects on meibomian gland function may also begin to emerge around this timeframe — the combination tends to show clearer results than either intervention alone.
The honest caveat on dry eye supplements generally
Nutritional interventions for dry eye work best for mild-to-moderate disease with a significant inflammatory or nutritional-deficiency component. Severe dry eye disease — particularly when structural meibomian gland dropout is advanced or when there is a significant autoimmune component (as in Sjogren’s syndrome) — requires medical management that supplements cannot replicate. Always work with an eye care professional for moderate-to-severe presentations.
If you are deciding whether to try Sightfresh, the Does Sightfresh Really Work? article walks through the evidence for its core mechanisms more broadly.
How Sightfresh Compares to Dedicated Dry Eye Supplements
Being clear about how Sightfresh positions against formulas specifically engineered for dry eye is a service to readers who are trying to decide whether this is the right product for their specific situation.
Dedicated Omega-3 formulations (e.g., ProDHA Eye, Nordic Naturals Eye Health Omega)
These supplements deliver therapeutic doses of EPA+DHA (typically 1,000–3,000 mg combined per serving), sometimes with the addition of GLA (gamma-linolenic acid from borage or evening primrose oil) for additional anti-inflammatory coverage. They target the meibomian gland and tear film lipid layer mechanism more directly than anything in Sightfresh’s formula. For someone whose primary diagnosis is evaporative dry eye with meibomian gland dysfunction, a dedicated Omega-3 product is better-targeted and has more direct clinical trial evidence supporting it.
Sightfresh wins on: macular protection, broader antioxidant coverage, multi-mechanism botanical anti-inflammatory support, and the convenience of a single formula for someone managing both macular and dry eye concerns.
Dedicated Omega-3 wins on: direct clinical evidence for dry eye-specific outcomes, meibomian gland support, and primary intervention for tear film lipid layer instability.
Comparison to other macular supplements with partial dry eye relevance
Against formulas like TheyaVue that share a similar macular-primary design philosophy, Sightfresh’s Quercetin 500 mg is a meaningful differentiator — Quercetin is dosed more generously here than in many competing macular formulas, and it is the ingredient most directly relevant to the inflammatory component of dry eye. Users comparing the two brands specifically for dry eye support should weight this difference. See our TheyaVue for Dry Eyes article for a parallel analysis.
For a broader vision supplement comparison that includes formulas across different design philosophies, the iGenics for Eyes article provides another reference point.
The composite picture
Sightfresh occupies a genuinely useful middle-ground position: more comprehensive macular support than most dry eye supplements, and more anti-inflammatory botanical coverage than most basic macular formulas. For the overlap population — people managing macular risk while also experiencing dry eye — it is a more efficient choice than taking two separate supplements. It is less efficient than a dedicated Omega-3 formula for someone whose sole concern is tear film stability.
See Is Sightfresh Legit? for our assessment of the manufacturer and the formula’s overall quality positioning.
Visit Official Site — Risk-Free 60-Day Money-Back Guarantee
Sightfresh is backed by a full 60-day money-back guarantee — time enough to determine whether its anti-inflammatory and antioxidant support makes a difference for your dry eye comfort alongside your macular health.
Check Sightfresh Pricing and Availability{rel=“nofollow sponsored”}
Frequently Asked Questions
Does Sightfresh help with dry eyes?
Sightfresh contains anti-inflammatory ingredients — Quercetin 500 mg, Bilberry Extract 160 mg, and Eyebright 400 mg — that may reduce the ocular surface inflammation that perpetuates dry eye syndrome. It also provides antioxidant protection through Lutein and Zeaxanthin that supports corneal and conjunctival tissue health. However, Sightfresh’s primary design targets macular health, not tear film production, and it lacks Omega-3 fatty acids, which have the strongest published evidence for improving tear film stability and reducing dry eye symptoms. Sightfresh can be a reasonable complementary supplement for dry eye, particularly for those also managing macular concerns — but it is not a substitute for a dedicated Omega-3 intervention if dry eye is your primary concern.
What is the best supplement for dry eyes?
Omega-3 fatty acids (EPA + DHA from fish oil or algae, targeting 1,000–2,000 mg combined per day) represent the nutritional intervention with the most extensive clinical trial evidence for dry eye syndrome. They support meibomian gland function, improve tear film lipid layer quality, and reduce the inflammatory signaling that drives dry eye chronicity. For those who want additional anti-inflammatory and antioxidant coverage — particularly if they also have macular health concerns — a broad-spectrum eye supplement like Sightfresh can be a meaningful addition to an Omega-3 foundation. Our Dry Eye Supplements Evidence guide covers the full comparative landscape.
Can I take Sightfresh for both dry eyes and macular health?
Yes — this is arguably Sightfresh’s strongest use case from a dry eye standpoint. Its core formula provides AREDS2-aligned support for macular pigment density via Lutein and Zeaxanthin, while Bilberry, Quercetin, and Eyebright offer anti-inflammatory and antioxidant support that may benefit dry eye sufferers. For adults managing both concerns simultaneously, Sightfresh consolidates multiple beneficial mechanisms into a single daily supplement. Adding an Omega-3 supplement alongside Sightfresh creates a more comprehensive nutritional approach to dry eye without duplicating the macular coverage. See About Sarah Reynolds for my overall philosophy on supplement stacking.
How long does Sightfresh take to help with dry eye symptoms?
Anti-inflammatory effects from oral supplements like Quercetin and Bilberry accumulate more slowly than the immediate relief from lubricating eye drops. The realistic assessment window for oral supplement benefit in dry eye is 60–90 days of consistent daily use. Some users notice reduced visual fatigue and improved screen comfort within the first four weeks (Bilberry tends to act more quickly than the slower-accumulating carotenoids), but meaningful shifts in baseline dry eye comfort are more reliably assessed at the 8–12 week mark. Eye drops remain the appropriate tool for acute symptom relief during this period.
Is there a dedicated dry eye supplement that works better than Sightfresh for dry eye?
For primary dry eye syndrome — particularly evaporative dry eye with meibomian gland involvement — dedicated high-dose Omega-3 formulations have stronger and more condition-specific clinical evidence than Sightfresh. If your ophthalmologist or optometrist has identified dry eye as your primary diagnosis and you want the most directly supported nutritional intervention, start with Omega-3s. Sightfresh is better positioned as a comprehensive vision support formula with complementary anti-inflammatory properties, rather than a targeted dry eye treatment. Our Sightfresh Pricing guide covers cost considerations if you’re thinking about combining supplements.
Does Sightfresh contain Omega-3s?
No — Sightfresh does not contain DHA, EPA, or any Omega-3 fatty acids. Its formula is built around fat-soluble carotenoids (Lutein, Zeaxanthin), water-soluble flavonoids (Quercetin, Bilberry anthocyanins), and botanical extracts (Eyebright). This makes it complement rather than duplicate a fish oil or algae-based Omega-3 supplement. If dry eye is a significant concern for you, I recommend pairing Sightfresh with a quality Omega-3 supplement rather than relying on Sightfresh alone for tear film support. The Sightfresh Ingredients article covers the complete formula.
Get Sightfresh Now — Risk-Free with 60-Day Money-Back Guarantee{rel=“nofollow sponsored”}
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.